Literature DB >> 16482563

Polymorphisms in the genes involved in the arachidonic acid-pathway, fish consumption and the risk of colorectal cancer.

Christine L E Siezen1, H Bas Bueno-de-Mesquita, Petra H M Peeters, Nicolien R Kram, Marina van Doeselaar, Henk J van Kranen.   

Abstract

The objective of this study on colorectal cancer was to investigate the associations between SNPs in the genes involved in the arachidonic acid (AA)-pathway, their haplotypes and colorectal cancer. Moreover, interactions between SNPs and fish consumption were considered. In this study, a total of 508 cases and 772 controls were included, originating from 2 prospective cohorts, the Monitoring Project on Cardiovascular Disease Risk Factors (PPHV) and Diagnostisch Onderzoek Mammacarcinoom (DOM). Genotypes of 23 SNPs in 7 candidate genes were determined and the modifying effect of fish consumption was considered. A protective effect of the minor allele of SNP V102V in PTGS2 was observed (odds ratio (OR), 0.37; 95% confidence intervals (CI), 0.16-0.87). The haplotype representing this allele showed a weaker inverse association, indicating that 2 alleles are necessary to obtain this protective effect. Fish consumption data was available for 209 cases and 418 controls. Increased fish consumption was inversely associated with cancer, although not significant (OR, 0.83; 95% CI, 0.57-1.20). Despite the substantial reductions in cancer risk for some genotypes in combination with high fish intake, no significant interactions between any SNP studied and fish consumption were observed. We have previously described an association between colorectal adenomas and SNP V102V in PTGS2 and have now confirmed this association for colorectal adenocarcinomas. Fish consumption of once a week or more might protect against colorectal cancer, but no significant interactions with SNPs in the genes involved in the AA-pathway could be detected within the study. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16482563     DOI: 10.1002/ijc.21858

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

1.  Peroxisome proliferator-activated receptor-gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis.

Authors:  Yong-Liang Lu; Gai-Ling Li; Hui-Lian Huang; Jing Zhong; Li-Cheng Dai
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

2.  Polymorphic human prostaglandin H synthase-2 proteins and their interactions with cyclooxygenase substrates and inhibitors.

Authors:  W Liu; E M Poole; C M Ulrich; R J Kulmacz
Journal:  Pharmacogenomics J       Date:  2010-06-15       Impact factor: 3.550

3.  PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer.

Authors:  Nina Habermann; Cornelia M Ulrich; Abbie Lundgreen; Karen W Makar; Elizabeth M Poole; Bette Caan; Richard Kulmacz; John Whitton; Rachel Galbraith; John D Potter; Martha L Slattery
Journal:  Genes Nutr       Date:  2012-06-08       Impact factor: 5.523

4.  An association between the PTGS2 rs5275 polymorphism and colorectal cancer risk in families with inherited non-syndromic predisposition.

Authors:  Jason Ross; Linda Lockett; Diana Brookes; Bruce Tabor; Konsta Duesing; Michael Buckley; Trevor Lockett; Peter Molloy; Finlay Macrae; Graeme Young; Ignacio Blanco; Gabriel Capella; Garry N Hannan
Journal:  Eur J Hum Genet       Date:  2013-03-27       Impact factor: 4.246

5.  Polymorphisms in regulatory regions of cyclooxygenase-2 gene and breast cancer risk in Brazilians: a case-control study.

Authors:  Diogo N Piranda; Juliana S Festa-Vasconcellos; Laura M Amaral; Anke Bergmann; Rosane Vianna-Jorge
Journal:  BMC Cancer       Date:  2010-11-08       Impact factor: 4.430

6.  Polymorphisms in arachidonic acid metabolism-related genes and the risk and prognosis of colorectal cancer.

Authors:  Shuying Li; Xiaojuan Zhao; Zhiwei Wu; Ye Li; Lin Zhu; Binbin Cui; Xinshu Dong; Suli Tian; Fulan Hu; Yashuang Zhao
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

7.  Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.

Authors:  Elizabeth L Barry; Leah B Sansbury; Maria V Grau; Iqbal U Ali; Shirley Tsang; David J Munroe; Dennis J Ahnen; Robert S Sandler; Fred Saibil; Jiang Gui; Robert S Bresalier; Gail E McKeown-Eyssen; Carol Burke; John A Baron
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-15       Impact factor: 4.254

8.  Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenoma.

Authors:  Zhihong Gong; Roberd M Bostick; Dawen Xie; Thomas G Hurley; Zonglin Deng; Dan A Dixon; Jinhui Zhang; James R Hebert
Journal:  Int J Colorectal Dis       Date:  2009-02-11       Impact factor: 2.571

9.  No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk.

Authors:  Cheryl-L Thompson; Sarah-J Plummer; Alona Merkulova; Iona Cheng; Thomas-C Tucker; Graham Casey; Li Li
Journal:  World J Gastroenterol       Date:  2009-05-14       Impact factor: 5.742

10.  Cyclooxygenase-2 gene polymorphisms and susceptibility to colorectal cancer in a Brazilian population.

Authors:  Michele Tatiana Pereira Tomitão; Sergio Carlos Nahas; Marcia Saldanha Kubrusly; Tatiane Katsue Furuya; Marcio Augusto Diniz; Suely Kazue Nagahashi Marie; Adriana Vaz Safatle-Ribeiro; José Eluf-Neto; Ivan Cecconello; Ulysses Ribeiro Junior
Journal:  J Gastrointest Oncol       Date:  2017-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.